10x Genomics, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that 10x Genomics, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $75.29M | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $61.21M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $55.82M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $53.58M | Feb 27, 2020 |
| FY2019 | Dec 31, 2018 | $50.55M | Feb 27, 2020 |
| FY2019 | Sep 30, 2018 | $36.61M | Feb 27, 2020 |
| FY2019 | Jun 30, 2018 | $31.74M | Feb 27, 2020 |
| FY2019 | Mar 31, 2018 | $27.41M | Feb 27, 2020 |
| FY2019 | Dec 31, 2017 | $71.09M | Feb 27, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $642.82M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $610.79M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $618.73M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $516.41M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $490.49M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $298.85M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $245.89M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $146.31M | Feb 26, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $443.88M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $414.48M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $409.31M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $396.02M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $416.40M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $240.38M | Feb 16, 2023 |
| FY2019 | Dec 31, 2019 | $58.71M | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $45.73M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $40.81M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $39.61M | Feb 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($43.54M) | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | ($182.63M) | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | ($255.10M) | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | ($166.00M) | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | ($58.22M) | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | ($542.73M) | Feb 16, 2023 |
| FY2019 | Dec 31, 2019 | ($7.13M) | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | ($9.60M) | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | ($10.88M) | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | ($3.64M) | Feb 27, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($60.99M) | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | ($194.56M) | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | ($265.33M) | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | ($167.94M) | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | ($52.25M) | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | ($534.14M) | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | ($30.57M) | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | ($110.76M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | ($18.38M) | Feb 27, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $316.13M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $344.34M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $343.33M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $298.30M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $257.56M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $202.33M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $130.83M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $87.94M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $46.74M | Feb 27, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $136.05M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $6.66M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | ($15.20M) | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | ($33.61M) | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | ($21.37M) | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | ($217.90M) | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $34.63M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | ($76.41M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | ($10.70M) | Feb 27, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.94M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $12.39M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $48.60M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $131.66M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $101.28M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $36.67M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $42.74M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $6.28M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $3.76M | Feb 27, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.04B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $918.64M | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $965.14M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $1.03B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $1.02B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $929.34M | Feb 18, 2022 |
| FY2020 | Jan 1, 2020 | $45.60M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $605.92M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $124.31M | Feb 27, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $245.04M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $208.50M | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $224.10M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $223.24M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $201.26M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $190.27M | Feb 18, 2022 |
| FY2020 | Jan 1, 2020 | $78.14M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $185.84M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $101.05M | Feb 27, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $796.33M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $710.13M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $741.04M | Feb 13, 2026 |
| FY2025 | Dec 31, 2022 | $805.74M | Feb 13, 2026 |
| FY2024 | Dec 31, 2021 | $817.57M | Feb 13, 2025 |
| FY2023 | Dec 31, 2020 | $739.07M | Feb 15, 2024 |
| FY2022 | Dec 31, 2019 | $420.08M | Feb 16, 2023 |
| FY2021 | Dec 31, 2018 | ($219.99M) | Feb 18, 2022 |
| FY2020 | Dec 31, 2017 | ($112.51M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | ($96.43M) | Feb 27, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.51M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $4.51M | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $4.51M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $4.51M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $4.51M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Feb 18, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.51B) | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | ($1.47B) | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | ($1.28B) | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | ($1.03B) | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | ($863.32M) | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | ($805.10M) | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | ($262.37M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | ($231.12M) | Feb 27, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $344.07M | Feb 13, 2025 |
| FY2024 | Dec 31, 2023 | $359.28M | Feb 13, 2025 |
| FY2024 | Dec 31, 2022 | $219.75M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $587.45M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $663.60M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $424.17M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $65.08M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $47.86M | Feb 27, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $29.72M | Feb 27, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | (2) | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | (5) | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 18, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | (2) | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | (5) | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 18, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 127.69M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 122.29M | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | 119.10M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | 115.20M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | 112.51M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | 108.49M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | 96.24M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 14.55M | Feb 27, 2020 |